Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Summary
The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select others. In a first step, the teams will focus on standardising the pre-analytical stages and defining a threshold of positivity. The results of microRNA signature on a cohort of 70 patients will be compared with the ultrasound and then histological data of the resection specimen.
Official title: Study of the Predictive Value of a Signature of microRNA in Thyroid Cytologies of Undetermined Type
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
71
Start Date
2021-06-17
Completion Date
2026-12
Last Updated
2025-09-23
Healthy Volunteers
No
Conditions
Interventions
Signature of microRNA for patients with bethesda classification 3, 4 or 5
If the cytology results are Bethesda 3, 4 or 5, then a miRNA analysis will be performed.
Locations (3)
CHU de Toulouse
Toulouse, Haute-Garonne, France
Institut régional du Cancer de Montpellier
Montpellier, Hérault, France
CHU de Nîmes
Nîmes, France